Janus Henderson Group PLC lessened its stake in shares of Masimo Co. (NASDAQ:MASI) by 23.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 359,454 shares of the medical equipment provider’s stock after selling 108,599 shares during the quarter. Janus Henderson Group PLC owned approximately 0.70% of Masimo worth $31,114,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. BlackRock Inc. lifted its holdings in shares of Masimo by 7.5% during the 2nd quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock valued at $721,710,000 after purchasing an additional 550,995 shares during the last quarter. Koch Industries Inc. lifted its holdings in shares of Masimo by 5,053.7% during the 2nd quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock valued at $439,000 after purchasing an additional 435,325 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Masimo by 76.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock valued at $73,191,000 after purchasing an additional 347,360 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Masimo by 6.9% during the 2nd quarter. Vanguard Group Inc. now owns 4,935,693 shares of the medical equipment provider’s stock valued at $450,036,000 after purchasing an additional 318,060 shares during the last quarter. Finally, Capital Fund Management S.A. lifted its holdings in shares of Masimo by 559.8% during the 2nd quarter. Capital Fund Management S.A. now owns 360,189 shares of the medical equipment provider’s stock valued at $32,842,000 after purchasing an additional 305,596 shares during the last quarter. 83.69% of the stock is currently owned by institutional investors and hedge funds.

Several analysts have recently commented on the company. BidaskClub lowered Masimo from a “hold” rating to a “sell” rating in a report on Thursday, December 7th. Stifel Nicolaus reiterated a “buy” rating and set a $108.00 price objective on shares of Masimo in a report on Friday, November 3rd. Finally, Zacks Investment Research upgraded Masimo from a “hold” rating to a “buy” rating and set a $98.00 price objective for the company in a report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the stock. Masimo has a consensus rating of “Hold” and a consensus price target of $97.17.

Shares of Masimo Co. (NASDAQ MASI) opened at $87.27 on Thursday. Masimo Co. has a twelve month low of $66.79 and a twelve month high of $104.71. The company has a market capitalization of $4,510.89, a price-to-earnings ratio of 33.45, a PEG ratio of 2.94 and a beta of 0.72.

Masimo (NASDAQ:MASI) last issued its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.17. The company had revenue of $193.69 million during the quarter, compared to analyst estimates of $189.01 million. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The firm’s quarterly revenue was up 15.6% on a year-over-year basis. During the same quarter last year, the business posted $0.52 EPS. analysts expect that Masimo Co. will post 2.95 earnings per share for the current year.

In related news, EVP Yongsam Lee sold 5,900 shares of the firm’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $88.31, for a total value of $521,029.00. Following the completion of the transaction, the executive vice president now owns 70,800 shares in the company, valued at approximately $6,252,348. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Steven Barker sold 10,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total value of $900,000.00. Following the completion of the transaction, the director now owns 73,249 shares of the company’s stock, valued at approximately $6,592,410. The disclosure for this sale can be found here. Insiders sold a total of 53,074 shares of company stock valued at $4,737,245 in the last 90 days. 16.60% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://www.watchlistnews.com/janus-henderson-group-plc-sells-108599-shares-of-masimo-co-masi/1775693.html.

Masimo Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.